Status | Study |
Recruiting |
Study Name: Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research Condition: Eosinophilia Date: 2004-09-01 |
Recruiting |
Study Name: Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome Condition: Hypereosinophilic Syndrome Date: 2002-08-24 Interventions: Drug: Imatinib Mesylate Imatinib is a tyrosine kinase inhibitor that selectively inhibits bcr-abl, c-kit |
Completed |
Study Name: Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome Condition: Hypereosinophilic Syndrome Date: 2001-06-15 Interventions: Drug: SCH55700 |
Completed |
Study Name: L-5-HTP-Related EMS Condition: Eosinophilia-Myalgia Syndrome Date: 1999-11-03 |
Recruiting |
Study Name: Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia Condition: Asthma Eosinophilia Helminthi Date: 1999-11-03 |